학술논문

ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms
Document Type
Article
Source
In: Molecular Cancer Therapeutics. (Molecular Cancer Therapeutics, 1 March 2024, 23(3):368-380)
Subject
Language
English
ISSN
15388514
15357163